The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression (Q37356791)

19 August 2017

The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression (English)

1 reference

primary biliary cholangitis

19 August 2017

0 references

0 references

Yoshihiko Maehara

1 reference

19 August 2017

Munechika Enjoji

1 reference

19 August 2017

Ryoko Yada

1 reference

19 August 2017

Tatsuya Fujino

1 reference

19 August 2017

Tsuyoshi Yoshimoto

1 reference

19 August 2017

Masayoshi Yada

1 reference

19 August 2017

Naohiko Harada

1 reference

19 August 2017

Nobito Higuchi

1 reference

19 August 2017

Masaki Kato

1 reference

19 August 2017

Motoyuki Kohjima

1 reference

19 August 2017

Akinobu Taketomi

1 reference

19 August 2017

Manabu Nakashima

1 reference

19 August 2017

Kazuhiro Kotoh

1 reference

19 August 2017

Makoto Nakamuta

1 reference

19 August 2017

16 June 2009

1 reference

19 August 2017

Hepatology international

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

490-496

1 reference

Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Protein sensors for membrane sterols

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Biliary lipids, water and cholesterol gallstones

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Fenofibrate for patients with asymptomatic primary biliary cirrhosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Genetic cholestasis, causes and consequences for hepatobiliary transport

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

The multidrug resistance protein family.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Multidrug resistance3 is in situ detected in the liver of patients with primary biliary cirrhosis, and induced in human hepatoma cells by bezafibrate.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2748377

Bezafibrate induces multidrug-resistance P-Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice

2 September 2018

1 reference

12 December 2020

Reduced hepatic expression of adipose tissue triglyceride lipase and CGI-58 may contribute to the development of non-alcoholic fatty liver disease in patients with insulin resistance

1 reference

12 December 2020

Cholesterol and non-cholesterol sterol transporters: ABCG5, ABCG8 and NPC1L1: a review

1 reference

12 December 2020

Bezafibrate treatment: a new medical approach for PBC patients?

1 reference

12 December 2020

10.1007/S12072-009-9137-Y

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19669248

1 reference